Trexquant Investment LP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$931,507
-78.4%
84,147
-68.4%
0.02%
-79.6%
Q2 2023$4,317,031
+276.2%
266,319
+286.4%
0.11%
+253.1%
Q1 2023$1,147,601
+10.6%
68,925
-37.6%
0.03%
+10.3%
Q4 2022$1,037,892
+1106.9%
110,414
+490.0%
0.03%
+480.0%
Q4 2021$86,000
-26.5%
18,714
+0.5%
0.01%
-44.4%
Q3 2021$117,000
-8.6%
18,630
-12.5%
0.01%
-18.2%
Q2 2021$128,000
+15.3%
21,301
+8.0%
0.01%
-8.3%
Q4 2020$111,000
-68.9%
19,721
-67.9%
0.01%
-47.8%
Q3 2020$357,000
+27.0%
61,423
-4.6%
0.02%
+15.0%
Q1 2018$281,00064,4130.02%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders